Changes in erythrocyte membranes during preparation, as expressed by ATPase activity.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D002417:Cattle; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D004789:Enzyme Activation; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D005260:Female; D005615:Freezing; D006041:Goats; D006461:Hemolysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007038:Hypotonic Solutions / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009996:Osmotic Fragility; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013045:Species Specificity
D007038:Hypotonic Solutions; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium